[ad_1]
Owen Mumford, a specialist in the design, manufacture and advancement of medical devices, achieved B Corp certification after demonstrating compliance with the requirements of this mark.
Owen Mumford, who established his sustainability program in 2014 and formally committed to the United Nations Sustainable Development Goals (SDGs), now joins a respected community of for-profit companies that are applying growth and profit to the positive benefit of the environment and external communities, as well as employees.
The B Corp certification evaluates five areas of impact: governance, community, workers, environment and customers.
Jarl Severn, CEO of Owen Mumford, said: Our social and environmental responsibilities have always been at the top of Owen Mumford’s agenda. Undergoing the rigorous B Corp certification process is a natural development of our core principles. Companies like ours that operate in the medical sector are used to the demands of a strictly regulated environment. We believe that it is not enough to simply declare ethical and environmental aspirations, but it is also essential to obtain a recognized certification. After all, our markets depend on the best ethical standards to protect environments, professionals and patients. B Corp provides a solid benchmark to continually improve what we do in our business, in the global communities we are a part of and in those where it can have a positive impact.
Owen Mumford has been designing and manufacturing medical devices for self-injection, blood sampling and drug delivery for nearly 70 years. This milestone firmly underlines its commitment to making a positive difference on social and environmental impact.
Kate Sandle, Director of Programs and Engagement at B Lab UK, said: We are delighted to welcome Owen Mumford to the B Corp community. business and believe that business can truly be a positive force. We know that Owen Mumford will be a fantastic addition to the community and will continue to carry the conversation forward. Welcoming Owen Mumford is an exciting time as he has the opportunity to lead the way in the medical device industry.
[ad_2]
picture credit